Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparin
- 15 October 1991
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 64 (2) , 131-141
- https://doi.org/10.1016/0049-3848(91)90113-b
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Structure and Activity of Heparin and Its Fragments: An OverviewSeminars in Thrombosis and Hemostasis, 1989
- Chemical and Biological Heterogeneity in Low Molecular Weight Heparins: Implications for Clinical Use and StandardizationSeminars in Thrombosis and Hemostasis, 1989
- Standardization of heparins by means of high performance liquid chromatography equipped with a low angle laser light scattering detectorThrombosis Research, 1987
- The Molecular Weight Distribution of Heparin Determined with a HPLC-LALLS Coupling TechniqueJournal of Liquid Chromatography, 1986
- Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersThrombosis Research, 1986
- Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationThrombosis Research, 1985
- High-pressure size-exclusion chromatography of anticoagulant materialsJournal of Chromatography A, 1984
- Characterization of heparins by high-performance size exclusion liquid chromatographyJournal of Chromatography A, 1983
- Molecular Weight Determination of Commercial Heparin Sodium USP and Its Sterile SolutionsJournal of Pharmaceutical Sciences, 1979
- Accurate and Reproducible Determination of Molecular Weight Distribution of Sodium Heparin U.S.P. By HPLCAnalytical Letters, 1976